09.15.26 -- Managing The Presence Of Visible Particulates In Cell Therapies

Automated bioprocessing platforms transform complex cell therapy workflows into scalable, fully compliant manufacturing pathways to lower costs and expand access.

Reliable labeling strategies solve the operational challenges of handling small batches of vials, syringes, and cartridges that standard equipment misses.

Automation continues to accelerate progress in life sciences and is preparing today’s PD labs for deeper autonomy. See how collaborative innovation can pave the way for smarter operations.

Disconnected manufacturing data limits quality and AI readiness. A connected IT/OT foundation helps teams reduce downtime, improve QC speed, and turn production data into trusted intelligence.

Uncover how plant-based peptones support E. coli growth, plasmid yield, and controlled induction, offering a sustainable, animal-free alternative for biopharmaceutical cell culture.

Researchers are advancing engineered mesenchymal stem cells using efficient non-viral gene delivery, enabling scalable, targeted therapies for solid tumors while preserving tumor-homing function and manufacturability.

Tube welding and biosafety cabinets present significant costs and risks for small-volume aseptic processing. Modern single-use aseptic connectors offer a more efficient alternative.

Siloed data and disconnected systems block analytics in life sciences manufacturing. Learn to bridge the infrastructure gap and build a connected foundation for scalable intelligence.

Implement this material transfer workflow to safeguard your cleanroom. Focus on barrier integrity, meticulous wiping, and surface preparation to reduce contamination risks.

To maximize the results of viral titer and full capsids, it's necessary to undertake systematic process development and optimization of AAV production. The choice of cell culture medium is foundational.

Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.

Harnessing the power of AI, biotherapeutic developers can better understand cellular processes and outcomes, paving the way for more personalized and effective treatments for patients.

Review the elements of a complex process, prone to misconceptions and pitfalls, to find the “right human tissue” that will yield the desired cell quality and quantity and pass BLA approval.

Gain insight into automating DNA size selection that shows how optimized bead ratios and programmable handling improve fragment recovery, consistency, and throughput.